{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T02:56:55Z","timestamp":1769569015669,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xjidi.2025.100399","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:09:36Z","timestamp":1751890176000},"page":"100399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Divergence in Estimated Risks and Actual Rates of Atherosclerotic Cardiovascular Events and their Management in a Longitudinal Cohort of Patients with Dermatomyositis with Skin Involvement"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8005-9111","authenticated-orcid":false,"given":"Megan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4151-7228","authenticated-orcid":false,"given":"Rui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-5369","authenticated-orcid":false,"given":"Victoria P.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-2159","authenticated-orcid":false,"given":"Kevin Jon","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2025.100399_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/bjd.18223","article-title":"Evaluating important change in cutaneous disease activity as an efficacy measure for clinical trials in dermatomyositis","volume":"182","author":"Ahmed","year":"2020","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"10.1016\/j.xjidi.2025.100399_bib3","first-page":"S20","article-title":"2. Diagnosis and classification of diabetes: standards of care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.xjidi.2025.100399_bib4","first-page":"S111","article-title":"6. Glycemic goals and hypoglycemia: standards of care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xjidi.2025.100399_bib5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bjd.13915","article-title":"Validation of the cutaneous dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change","volume":"173","author":"Anyanwu","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2025.100399_bib6","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.xjidi.2025.100399_bib7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/clc.23375","article-title":"Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: a retrospective study","volume":"43","author":"Bae","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.xjidi.2025.100399_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jacc.2023.10.039","article-title":"Lipoprotein(a) is markedly more atherogenic than LDL: an apolipoprotein B-based genetic analysis","volume":"83","author":"Bj\u00f6rnson","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.xjidi.2025.100399_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity","volume":"27","author":"Bor\u00e9n","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.xjidi.2025.100399_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","article-title":"Dermatomyositis","volume":"355","author":"Callen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.xjidi.2025.100399_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jaad.2017.10.022","article-title":"Cutaneous dermatomyositis disease course followed over time using the cutaneous dermatomyositis Disease Area and Severity Index","volume":"79","author":"Chansky","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2025.100399_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jaad.2022.03.054","article-title":"Preliminary definition of cutaneous flare in dermatomyositis: a retrospective review","volume":"88","author":"Dan","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2025.100399_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/bjd\/ljad133","article-title":"A comparison of the efficacy of Skindex-16 and Skindex-29 in dermatomyositis","volume":"189","author":"Dan","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2025.100399_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2337\/dc18-1970","article-title":"Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the diabetes prevention program and diabetes prevention program outcomes study","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xjidi.2025.100399_bib15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.xjidi.2025.100399_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000272","article-title":"QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus","volume":"5","author":"Edwards","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.xjidi.2025.100399_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jacc.2022.06.007","article-title":"Interpreting the clinical implications of drug-target Mendelian randomization studies","volume":"80","author":"Ference","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.xjidi.2025.100399_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025858","article-title":"Physiological bases for the superiority of apolipoprotein B over low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as a marker of cardiovascular risk","volume":"11","author":"Glavinovic","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.xjidi.2025.100399_bib19","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/CIRCULATIONAHA.121.056756","article-title":"Effects of long-term metformin and lifestyle interventions on cardiovascular events in the diabetes prevention program and its outcome study","volume":"145","author":"Goldberg","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.xjidi.2025.100399_bib20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaad.2010.10.016","article-title":"Quality of life in dermatomyositis","volume":"65","author":"Goreshi","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2025.100399_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjd.21235","article-title":"Mycophenolate mofetil and methotrexate efficacy in dermatomyositis","volume":"187","author":"Grinnell","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2025.100399_bib21","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.xjidi.2025.100399_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.xjidi.2025.100399_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ijwd.2021.08.015","article-title":"Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis","volume":"7","author":"Keyes","year":"2021","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.xjidi.2025.100399_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl. 4","key":"10.1016\/j.xjidi.2025.100399_bib25","doi-asserted-by":"crossref","first-page":"iv18","DOI":"10.1093\/rheumatology\/kel311","article-title":"The heart in dermatomyositis and polymyositis","volume":"45","author":"Lundberg","year":"2006","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.xjidi.2025.100399_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.xjidi.2025.100399_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1214\/aoms\/1177730491","article-title":"On a test of whether one of two random variables is stochastically larger than the other","volume":"18","author":"Mann","year":"1947","journal-title":"Ann Math Statist"},{"key":"10.1016\/j.xjidi.2025.100399_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1118620","article-title":"Predictive model of diabetes mellitus in patients with idiopathic inflammatory myopathies","volume":"14","author":"Nie","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.xjidi.2025.100399_bib29","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/jch.14267","article-title":"Development of the prediction model for hypertension in patients with idiopathic inflammatory myopathies","volume":"23","author":"Qin","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.xjidi.2025.100399_bib31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jaad.2020.07.081","article-title":"Response of dermatomyositis to the antimalarial quinacrine: a retrospective cohort study","volume":"84","author":"Ravishankar","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2025.100399_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.otohns.2010.05.007","article-title":"A practical guide to understanding Kaplan-Meier curves","volume":"143","author":"Rich","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.xjidi.2025.100399_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14942","article-title":"Treatment challenges in clinically amyopathic dermatomyositis: a case series and review of new therapeutic options for skin involvement","volume":"34","author":"Rodr\u00edguez-Tejero","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.xjidi.2025.100399_bib34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/BOR.0b013e32833f1987","article-title":"Clinically amyopathic dermatomyositis","volume":"22","author":"Sato","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.xjidi.2025.100399_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000291","article-title":"Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies","volume":"2","author":"Schwartz","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.xjidi.2025.100399_bib36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"key":"10.1016\/j.xjidi.2025.100399_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jamacardio.2021.4987","article-title":"Treating severe hypercholesterolemia-if not now, when?","volume":"7","author":"Stone","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.xjidi.2025.100399_bib38","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","author":"Di Angelantonio","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.xjidi.2025.100399_bib39","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s10067-014-2561-y","article-title":"Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients","volume":"33","author":"Vincze","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.xjidi.2025.100399_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-3083.2011.04437.x","article-title":"Lipid profiles in untreated patients with dermatomyositis","volume":"27","author":"Wang","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2025.100399_bib41","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.xjidi.2025.100399_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/ATVBAHA.123.320065","article-title":"Eradicating atherosclerotic events by targeting early subclinical disease: it is time to retire the therapeutic paradigm of too much, too late","volume":"44","author":"Williams","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.xjidi.2025.100399_bib43","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.xjidi.2025.100399_bib44","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 Trial of a statin, placebo, or no treatment to assess side effects","volume":"383","author":"Wood","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xjidi.2025.100399_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000908","article-title":"State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus","volume":"10","author":"Zhao","year":"2023","journal-title":"Lupus Sci Med"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026725000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026725000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:07:00Z","timestamp":1769522820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026725000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2667026725000554"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2025.100399","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergence in Estimated Risks and Actual Rates of Atherosclerotic Cardiovascular Events and their Management in a Longitudinal Cohort of Patients with Dermatomyositis with Skin Involvement","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2025.100399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100399"}}